Pharma & Biotech

Biopharmaceutical company Incyte may be on the verge of a significant advancement for its dermatology division. New long-term results for...

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with results exceeding market...

While market headlines often focus on technology giants, a significant transformation is unfolding within the healthcare diagnostics sector. Quest Diagnostics,...

A landmark expansion of Monte Rosa Therapeutics' existing collaboration with pharmaceutical leader Novartis has ignited a dramatic surge in its...

The markets are presenting a puzzling contradiction with Dynavax Technologies Corporation. The biopharmaceutical company recently reported record-breaking financial results and...

In a notable strategic shift, Pfizer and its collaborator Arvinas have announced they will seek an external commercialization partner for...

Global alternative asset manager TPG is actively pursuing major acquisitions across multiple sectors, demonstrating its aggressive growth strategy. The firm...

Embecta, a specialized diabetes care company, is currently presenting investors with a puzzling dichotomy. Despite posting solid quarterly figures and...

Viking Therapeutics shares are experiencing a severe sell-off, extending recent losses with a further 1.64% decline over the past trading...

In a landmark transaction that concludes its 124-year history as a publicly traded company, Walgreens Boots Alliance has been formally...